1. Comparability Protocols for postapproval changes to the chemistry, manufacturing, and controls information in an NDA, ANDA, or BLA: guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, October 2022 Subject(s): Biological ProductsDrug ApprovalGovernment RegulationUnited StatesUnited States. Food and Drug Administration